Keywords
Vaccinatio
Pandemic COVID-19
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the impact of the COVID-19 pandemic on anti-HPV vaccine coverage (CV) in children and adolescents of both sexes aged 9 to 14 years vaccinated with the first and/or second dose of the anti-HPV vaccine, recorded in the SI-PNI Web, between the years 2018 to 2021. Methods: This is a descriptive, cross-sectional study with a quantitative approach. Data were collected through TabNet, notified to SI-PNI Web. The female population aged between nine and 26 years with HIV/AIDS were excluded. Results: The years 2018 and 2021 had, respectively, the highest and lowest percentages of VC for two doses of the HPV vaccine. The second dose presented a median percentage or below the average in all Brazilian regions. As of March 2020, when the first cases of covid-19 were registered, there was a decrease in the number of vaccines applied and an exponential growth in the number of cases of HPV, gradually decreasing in 2021. Conclusion: The pandemic has directly impacted the reduction of CV and increase in the number of HPV cases in all five regions of the country, however it is still important to note that adherence for this specific vaccine is low.
References
BENEDETTI M, et al. Impacto da pandemia da covid-19 na cobertura vacinal no estado de Roraima, Amazônia Ocidental, Brasil. The Brazilian Journal of Infectious Diseases: an Official Publication of the Brazilian Society of Infectious Diseases. 2022; 26(1): 101874-101874.
BRITO PF e SOUZA EP. Cobertura vacinal do HPV para adolescentes: desafios e possibilidades. Id on Line Revista de Psicologia, 2017; 11(38): 530-540.
BRASIL. Resolução nº 466, de 12 de dezembro de 2012. Dispõe sobre diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial [da] República Federativa do Brasil, 13 jun. 2013.
BRASIL. Ministério da Saúde. Queda nos índices das coberturas vacinais no Brasil. 2018.
CANFELL K. Towards the global elimination of cervical cancer. Papillomavirus research, 2019; (8): 100170.
CAVALCANTE RL, et al. Impact of the COVID-19 pandemic on the immunization of the Human Papillomavirus vaccine among children and adolescents aged 9 to 14 years in the Xingu – Pará. Research, Society and Development, 2021; 10(4): e36310413987.
CAVALCANTI GM, et al. Impacto da pandemia de COVID-19 no rastreamento do câncer do colo do útero na cidade do sul do Maranhão. Pesquisa, Sociedade e Desenvolvimento, 2022; 11(4): e24011427161.
DAMGACIOGLU H, et al. Long-term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: A modeling study. Lancet, 2022; 8: 100143.
FERREIRA MCD, et al. Incidência e mortalidade por câncer de mama e colo do útero em uma cidade brasileira. Revista de Saúde Pública, 2021; 55.
GOMES JM, et al. Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance. Plos One, 2020; 15(11): e0241674.
JÚNIOR LCL, et al. Análise da cobertura vacinal durante a pandemia de COVID-19 em Vitória, Brasil. Journal of Human Growth and Development. 2021; 31(3): 387-397.
KARANJA-CHEGE CM. HPV vaccination in Kenya: The Challenges faced and Strategies to increase Uptake. Frontiers in Public Health, 2022; 204.
MIYOSHI A, et al. Contemplating HPV vaccination in Japan during the time of COVID-19. Human Vaccines & Immunotherapeutics. 2021; 17(3): 836-837.
MOURA LDL. Cobertura vacinal contra o Papilomavírus Humano (HPV) em meninas e adolescentes no Brasil: análise por coortes de nascimentos. Dissertação (Mestrado em Epidemiologia em Saúde Pública) Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil. 2019; 90.
MOURA LDL, et al Cobertura da vacina papilomavírus humano (HPV) no Brasil: heterogeneidade espacial e entre coortes etárias. Revista brasileira de epidemiologia, 2020; 24.
MUHOZA P, et al. Routine Vaccination Coverage—Worldwide, 2020. Morbi Mort We Rep, 2021; 70(43): 1495.
NASCIMENTO MID, et al. Mortalidade prematura por câncer de colo uterino: estudo de séries temporais interrompidas. Revista de Saúde Pública. 2020; 54. Organização Pan-Americana da Saúde - OPAS. Pesquisa de pulso sobre imunização. 2020.
ORGANIZAÇÃO PAN-AMERICANA DA SAÚDE - OPAS. Pesquisa de pulso sobre imunização. 2020.
PEREIRA N, et al. Human papillomavirus infection, infertility, and assisted reproductive outcomes. Journal of pathogens, 2015.
PINGALI C, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2020. Morbidity and Mortality Weekly Report, 2021; 70(35): 1183.
RYAN G. Challenges to Adolescent HPV Vaccination and Implementation of Evidence-Based Interventions to Promote Vaccine Uptake During the COVID-19 Pandemic: HPV Is Probably Not at the Top of Our List. Preventing chronic disease. 2020; 19.
SANTOS JGS e DIAS JMG. Vacinação pública contra o papilomavirus humano no Brasil. Rev Med Minas Gerais, 2018; 28(1): 1-7.
SATO APS. Pandemia e coberturas vacinais: desafios para o retorno às escolas. Rev Saú Púb, 2020; 54: 115.
SILVA TMR, et al. Impact of the COVID-19 Pandemic on Human Papillomavirus Vaccination in Brazil. International journal of public health, 2022; 67: 1604224.
SOCIEDADE BRASILEIRA E IMUNIZAÇÕES (INTERNET). Vacinação em dia, mesmo na pandemia [citado em 23 de agosto de 2021]. Disponível em: https://familia.sbim.org.br/videos/vacinacao-em-dia-mesmo-na-pandemia.
SOUSA LVDA, et al. Desigualdades na Mortalidade e Acesso à Atenção Hospitalar para o Câncer Cervical-Um Estudo Ecológico. Revista Internacional de Pesquisa Ambiental e Saúde Pública, 2021; 18(20): 10966.
TANAKA LM e FERREIRA MW. Impacto da pandemia (COVID-19) sobre as metas de imunização em crianças no estado do Paraná, Brasil (dissertação). Paraná. Unicesumar - Universidade Cesumar: Maringá, 2020.
TOH ZQ, et al. Vacinação contra o papilomavírus humano após COVID-19. JNCI cancer spectrum, 2021; 5(2): pkab011.